UBS Group
GWPH

UBS Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

UBS Group’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,000
Closed -$876K – 8589
2020
Q1 		$876K Sell
10,000
-104,700
-91% -$11.1M ﹤0.01% 3468
2019
Q4 		$12M Buy
114,700
+90,000
+364% +$10.1M ﹤0.01% 1792
2019
Q3 		$2.84M Buy
+24,700
New +$3.75M ﹤0.01% 2945
2017
Q2 		– Sell
-74,600
Closed -$9.02M – 8134
2017
Q1 		$9.02M Sell
74,600
-36,700
-33% -$4.5M ﹤0.01% 1595
2016
Q4 		$12.4M Buy
111,300
+111,200
+111,200% +$13.4M 0.01% 1336
2016
Q3 		$13K Sell
100
-10,500
-99% -$1M ﹤0.01% 6623
2016
Q2 		$971K Buy
10,600
+10,500
+10,500% +$884K ﹤0.01% 3406
2016
Q1 		$7K Sell
100
-200
-67% -$11K ﹤0.01% 6880
2015
Q4 		$21K Hold
300
– – ﹤0.01% 6734
2015
Q3 		$27K Hold
300
– – ﹤0.01% 6416
2015
Q2 		$37K Sell
300
-100
-25% -$11.3K ﹤0.01% 6290
2015
Q1 		$36K Sell
400
-3,000
-88% -$244K ﹤0.01% 6358
2014
Q4 		$230K Buy
+3,400
New +$248K ﹤0.01% 4915

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

UBS Group's GWPH Position: Q2 2021 in Review

UBS Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 35,553 shares — an estimated $7.71M sold.

UBS Group first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $18.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • UBS Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • UBS Group sold 35,553 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7.71M.
  • UBS Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
  • UBS Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18.6M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.